ALMUS
associated with 6 other trademarks
Pharmaceutical preparations for use in the treatment of Crohn's Disease, Ulcerative Colitis, severe eczema, Myasthenia Gravis and transplant rejection...

Words that describe this trademark:

ulcerative colitis severe  treatment crohns disease  pharmaceutical preparations  crohns disease  colitis severe  myasthenia gravis  severe eczema  disease  eczema  preparations 

Serial Number:

78292232

Mark:

ALMUS

Status:

Cancelled-Section 8

Status Date:

12-26-2014

Filing Date:

Registration Number:

3431108

Registration Date:

05-20-2008

Goods and Services:

Pharmaceutical preparations for use in the treatment of Crohn's Disease, Ulcerative Colitis, severe eczema, Myasthenia Gravis and transplant rejection; pharmaceutical preparations to treat the gastrointestinal system, the cardiovascular system, the respiratory system, the central nervous system, infection, the endocrine system, the urinary tract, blood, musculoskeletal and joint disease, eye, ear, nose and oropharynx, skin, and malignant disease, malignant disease being defined as Acute Lymphoblastic Leukaemia, Hodgkin's Disease, Non-Hodgkins Lymphomas and other oncological diseases; pharmaceutical preparations for use in nutrition namely for the treatment and prevention of scurvy or for the treatment of Vitamin B deficiency; immunosuppressants and immunological products, namely, products to treat autoimmune conditions such as Crohn's Disease, ulcerative colitis, severe eczema, Myasthenia Gravis and transplant rejection Medical services; advisory and consultation services relating to pharmaceutical and veterinary preparations; advisory and consultation services relating to medical conditions and diseases and the treatment thereof

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

03-04-2008

Mark Drawing Status:

Typed Drawing

Abandon Date:

N/A

Business Name:

DUANE MORRIS LLP

Correspondent Name:

Recent Trademark filings by this company